D. Chinnaraja et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 124 (2014) 30–33
31
possessing biological activities. This prompted us to synthesize
Synthesis of 1-thiocarbamoyl-3-pyridyl-5-(4-chlorophenyl)-2-pyraz
oline (8)
Yield: 70%; mp: 159 °C; white solid; molecular formula C15H13
N4SCl; IR
max(cmÀ1): 1604 (C@N); 1366 (CAN); 3043(ArAH);
various substituted N-thiocarbamoyl pyrazoline derivatives. In this
article we focus the characterization of biologically active pyrazo-
line derivatives and to supplement the XRD parameters, theoretical
calculations were made using Gaussian-03 package.
t
3442–3369 (NH2); 1H NMR (CDCl3) d(ppm): 3.3 (dd, 1H, HA, J1:
7.5, J2: 16.18), 3.9 (dd, 1H, HB, J1: 12.5, J2: 18), 6.3 (dd, 1H, HC, J1:
7.6 J2: 12.57), 6.5 and 6.4 (2H, NH2), 6.8–8.7(ArAH), 213C NMR
(CDCl3) d(ppm): 152.37 C@N, 177.67 (C@S), 43.08 CH2, 63.94 CH,
113.63–149.93(ArAC). Anal. Calcd. (%) for: C, 56.87; H, 4.17; N,
17.82. Found (%): C, 56.81; H, 4.11; N, 17.72; LC–MS (m/z): 316.
Experimental section
Instruments
The IR spectrum was recorded in AVATAR-330 FT-IR spectro-
photometer and only noteworthy absorption levels (reciprocal
centimeters) were listed. 1H NMR spectra were recorded at 300
and 400 MHz on Bruker AMX 300 and 400 MHz spectrophotometer
using CDCl3 as solvent and TMS as internal standard. 13C NMR
spectra were recorded at 75 and 100 MHz on Bruker AMX 300
and 400 MHz spectrophotometer using CDCl3. The tubes used for
recording NMR spectra were 5 mm diameter. The reactions and
the purity of the products were assessed by performing TLC. All
the reported melting points were taken in open capillaries and
were uncorrected. Geometry optimization was carried out by
Gaussion-03 (AM1) package for all the compounds (7–12).
Synthesis of 1-thiocarbamoyl-3-pyridyl-5-(4-methoxyphenyl)-
2-pyrazoline (9)
Yield: 70%; mp: 177 °C; pale yellow powder; molecular formula
C
16H16N4SO; IR t
max(cmÀ1): 1621 (C@N); 1378 (CAN); 3043
(ArAH); 3442–3369 (NH2); 1H NMR (CDCl3) d(ppm): 3.3 (dd, 1H,
HA, J1: 7.5, J2: 16.74), 4.0 (dd, 1H, HB, J1: 12, J2: 18), 6.1 (dd, 1H,
HC, J1: 7.6 J2: 12.45), 6.5 and 6.4 (2H, NH2), 3.9 (S,3H, OCH3),
6.8–8.5(ArAH), 13C NMR (CDCl3) d(ppm): 161.88 C@N, 177.92
(C@S), 50.00 CH2, 94.98 CH, 55.43 (OCH3), 114.22–149.21(ArAC).
Anal. Calcd. (%) for: C, 61.49; H, 5.03; N, 17.63. Found (%): C,
61.51; H, 5.12; N, 17.42; LC–MS (m/z): 312.
Synthesis of 1-thiocarbamoyl-3-pyridyl-5-(3,4-dimethoxyphenyl)-
2-pyrazoline (10)
Synthesis
Yield: 60%; mp: 147 °C; yellow solid; molecular formula C17H18
N4O2S; IR
t
max(cmÀ1): 1594 (C@N); 1387 (CAN); 3052(ArAH);
Synthesis of 1-thiocarbamoyl-3-pyridyl-5-phenyl-2-pyrazolines
(7–12)
3442–3369 (NH2); 1H NMR (CDCl3) d(ppm): 3.4 (dd, 1H, HA, J1:
7.6, J2: 16.82), 4.1 (dd, 1H, HB, J1: 12, J2: 18), 6.3 (dd, 1H, HC, J1:
7.6 J2: 12.33), 6.5 and 6.4 (2H, NH2), 3.8 (S,6H, (OCH3)2),
6.7–8.4(ArAH), 13C NMR (CDCl3) d(ppm): 161.61 C@N, 177.38
(C@S), 50.13 CH2, 95.22 CH, 56.16 (OCH3), 109.02–149.37(ArAC).).
Anal. Calcd. (%) for: C, 59.67; H, 5.47; N, 16.33. Found (%): C, 59.71;
H, 5.41; N, 16.37; LC–MS (m/z): 342.
Synthesis of pyrazoline derivative was performed in a manner
as outlined in Scheme S1. The cyclization of chalcones with thio-
semicarbazide under basic condition (anhydrous potassium car-
bonate) in 50 mL of ethanol led to the formation of pyrazoline
compound and it is stable in solid state. The structures of pyrazo-
line derivatives (7–12), are given in Scheme S1.
Synthesis of 1-thiocarbamoyl-3-pyridyl-5-(2,4-dichlorophenyl)-
2-pyrazoline (7)
Synthesis of 1-thiocarbamoyl-3-pyridyl-5-(3,4,5-trimethoxyphenyl)-
2-pyrazoline (11)
Yield 70%; mp 115 °C; white crystal; molecular formula C15H12
N4SCl2; tmax cmÀ1 1595 (C@N), 3061 (HC@Ar), 3442–3369 (NH2);
1H NMR (300 MHZ CDCl3) d(ppm): 3.3 (dd, 1H, J1 = 4.2HZ,
J2 = 18.9HZ, HA), 4.0 (dd, 1H, J1 = 11.7 3HZ, J2 = 18.9HZ HB), 6.2 (dd,
1H, J1 = 4.2HZ, J2 = 11.7HZ Hc), 6.5 and 6.4 (2H, NH2), 6.9–8.6 (m,
7H, ArAH); 13C NMR (75 MHZ CDCl3) d(ppm): 157.38 (C@N),
177.25 (C@S), 41.74(C-4), 61.23(C-5), 121.48–149.69 (aromatic
carbons). Anal. Calcd. (%) for: C, 51.29; H, 3.42; N, 15.93. Found
(%): C, 51.31; H, 3.40; N, 15.82; LC–MS (m/z): 350.
Yield: 65%; mp: 183 °C; pale yellow powder; molecular formula
C
18H20N4SO3S; IR t
max(cmÀ1): 1600 (C@N); 1385 (CAN); 3051
(ArAH); 3442–3369 (NH2); 1H NMR (CDCl3) d(ppm): 3.3 (dd, 1H,
HA, J1: 7.6, J2: 16.65), 4.1 (dd, 1H, HB, J1: 12, J2: 18), 6.2 (dd, 1H,
HC, J1: 7.6 J2: 18.41), 6.5 and 6.4 (2H, NH2), 3.9 (S, 9H, (OCH3)3),
6.8–8.5(ArAH), 13C NMR (CDCl3) d(ppm): 161.61 C@N, 177.74
(C@S), 50.63 CH2, 95.25 CH, 56.77 (OCH3), 110.05–149.65(ArAC).
Anal. Calcd. (%) for: C, 58.07; H, 5.31; N, 15.27. Found (%): C,
58.11; H, 5.22; N, 15.25; LC–MS (m/z): 372.
Table 1
The selected bond distance, bond angles and dihedral angle for compound 7.
Connectivity
Bond distance*
Connectivity
Bond angle*
Connectivity
Dihedral angle*
S1AC7
C1AN1
C5AN1
C5AC4
C7AN4
C6AN2
N2AN3
N3AC9
C6AC8
C8AC9
N3AC7
1.6838(1.6205)
1.3467(1.3612)
1.331(1.3421)
1.369(1.4088)
1.329(1.3685)
1.2817(1.5042)
1.3976(1.3608)
1.4839(1.3228)
1.492(1.5592)
1.542(1.5221)
1.354(1.425)
C7AN3AN2
N2AN3AC9
C6AN2AN3
C5AN1AC1
N2AC6AC8
N1AC1AC2
N4AC7AN3
N4AC7AS1
N3AC7AS1
C15AC10AC11
C6AC8AC9
N1AC5AC4
C13AC12AC11
C4AC3AC2
C3AC2AC1
N3AC9AC8
C12AC11AC10
118.37(121.71)
112.50(110.34)
107.91(111.91)
117.29(117.48)
114.92(102.98)
122.72(122.34)
116.11(118.72)
122.43(120.76)
121.46(120.44)
116.62(118.45)
102.63(101.58)
123.81(123.99)
118.76(119.42)
119.41(119.12)
118.32(118.93)
101.30(113.11)
122.35(120.93)
N3AN2AC6AC1
N2AC6AC1AC2
N2AC6AC1AN1
N2AN3AC7AS1
N2AN3AC7AN4
C9AN3AC7AS1
C7AN3AN2AC6
C9AN3AN2AC6
C7AN3AC9AC8
N2AN3AC9AC10
C9AC10AC15AC14
C9AC10AC11AC12
C6AC1AC2AC3
N1AC1AC2AC3
C1AN1AC5AC4
C6AC8AC9AN3
C6AC8AC9AC10
175.03(À176.40)
16.4(À169.02)
À160.89(10.97)
172.20(157.89)
À7.4(À24.80)
9.7(11.36)
À159.05(À149.93)
5.93(À1.43)
154.80(149.57)
112.45(119.86)
179.32(À179.77)
0.8(179.88)
À176.26(179.84)
0.8(À0.15)
1.9(0.06)
7.59(1.26)
À113.36(À120.97)
*
The values in the parenthesis are theoretically calculated.